Status:
COMPLETED
Randomized Contralateral Clinical Trial With Single-piece (SN60WF) vs. Three Piece (MA60AC) AcrySof Intraocular Lenses (IOLs) on Development of Posterior Chamber Opacification (PCO).
Lead Sponsor:
Alcon Research
Conditions:
Cataract
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Randomized contralateral clinical trial with single piece (Model SN60WF) vs. three piece (Model MA60AC) AcrySof Intraocular Lenses (IOLs) on development of Posterior Chamber Opacifiation (PCO).
Eligibility Criteria
Inclusion
- Age \> 50 years
- Clear cornea
- Pupil mydriasis ≥ 7mm
- In the bag Intraocular Lens (IOL)
Exclusion
- Ocular pathology - uveitis, glaucoma, pseudoexfoliation syndrome (PEX), high myopia
- Previously operated eye
- Proliferative diabetic retinopathy
- Surgical complications - incomplete rhexis, post capsular rupture (PCR), zonular dialysis
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT00758745
Start Date
January 1 2006
End Date
December 1 2009
Last Update
August 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Alcon Call Center for Study Locations
Fort Worth, Texas, United States, 76134